Zusammenfassung
Durch eine Masernvirusinfektion sind keine Schädigungen für den Embryo/Feten bekannt. Da eine Maserninfektion aber schwer verlaufen kann, sollen alle Frauen im gebärfähigen Alter gegen eine Masernerkrankung geschützt sein. Die Immunitätsbestimmung soll vor der Schwangerschaft durch eine Kontrolle des Impfausweises erfolgen. Der Schutz wird durch 2 dokumentierte Masern- oder MMR-Impfungen nachgewiesen. Eine Antikörperkontrolle wird in diesem Fall nicht empfohlen. Fehlende Impfungen sollen vor der Schwangerschaft entsprechend den STIKO-Empfehlungen verabreicht werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Aaby P, Bukh J, Lisse IM, Seim E, de Silva MC (1988) Increased perinatal mortality among children of mothers exposed to measles during pregnancy. Lancet 1:516–519
Aaby P, Seim E, Knudsen K, Bukh J, Lisse IM, da Silva MC (1990) Increased postperinatal child mortality among children of mothers exposed to measles during pregnancy. Am J Epidemiol 132(2):531–539
Ali ME, Albar HM (1997) Measles in pregnancy: maternal morbidity and perinatal outcome. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. Int J Gynaecol Obstet 59(2):109–113
Anselem O, Tsatsaris V, Lopez E, Krivine A, Le Ray C et al (2011) [Measles and pregnancy]. Presse Med. 40(11): 1001–1007
Atmar RL, Englund JA, Hammill H (1992) Complications of measles during pregnancy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 14:217–226
Barrabeig I, Rovira A, Munoz P, Batalla J, Rius C et al (2011) MMR vaccine effectiveness in an outbreak that involved day-care and primary schools. Vaccine 29:8024–8031
Betta Ragazzi SL, De Andrade Vaz-de-Lima LR, Rota P, Bellini WJ, Gilio AM et al (2005) Congenital and neonatal measles during an epidemic in Sao Paulo, Brazil in 1997. Pediatr Infect Dis J 24(4):377–378
Black FL (1959) Growth and stability of measles virus. Virology 7(2):184–192
Bolton P, Holt E, Ross A, Hughart N, Guyer B (1998) Estimating vaccination coverage using parental recall, vaccination cards, and medical records. Public Health Rep 113(6):521–526
Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM et al (1990) Measles antibody: reevaluation of protective titers. J Infect Dis 162(5):1036–1042
Chiba ME, Saito M, Suzuki N, Honda Y, Yaegashi N (2003) Measles infection in pregnancy. J Infect 47(1):40–44
Cruzado D, Masserey-Spicher V, Roux L, Delavelle J, Picard F, Haenggeli CA (2002) Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection. Eur J Pediatr 161(8):438–441
Dasopoulou, M, Covanis A (2004) Subacute sclerosing panencephalitis after intrauterine infection. Acta Paediatr 93(9):1251–1253
De Serres G, Markowski F, Toth E, Landry M, Auger D et al (2013) Largest measles epidemic in North America in a decade – Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis 207(6):990–998
Eberhart-Phillips JE, Frederick PD, Baron RC, Mascola L (1993) Measles in pregnancy: a descriptive study of 58 cases. Obstet Gynecol 82(5):797–801
Enders G (1984) [Accidental rubella vaccination in pregnancy]. Dtsch Med Wochenschr 109(47):1806–1809
Enders M, Biber M, Exler S (2007) [Measles, mumps and rubella virus infection in pregnancy. Possible adverse effects on pregnant women, pregnancy outcome and the fetus]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 50(11):1393–1398
Endo A, Izumi H, Miyashita M, Taniguchi K, Okubo O, Harada K (2001) Current efficacy of postexposure prophylaxis against measles with immunoglobulin. J Pediatr 138(6):926–928
Haukenes G, Viggen B, Boye B, Kalvenes MB, Flo R, Kalland KH (1994) Viral antibodies in infectious mononucleosis. FEMS Immunol Med Microbiol 8(3):219–224
Hofmann J, Kortung M, Pustowoit B, Faber R, Piskazeck U, Liebert UG (2000) Persistent fetal rubella vaccine virus infection following inadvertent vaccination during early pregnancy. J Med Virol 61(1):155–158
Jespersen CS, Littauer J, Sagild U (1966) [Measles in pregnancy as a cause of stillbirth and malformations. A retrospective study in Greenland]. Ugeskr Laeger 128(37):1076–1080
Jespersen CS, Littauer J, Sagild U (1977) Measles as a cause of fetal defects. A retrospective study of tem measles epidemics in Greenland. Acta Paediatr Scand 66(3):367–372
Kakoulidou M, Ingelman-Sundberg H, Johansson E, Cagigi A, Farouk SE et al (2013) Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults. Vaccine 31:711–717
Korones SB (1988) Uncommon virus infections of the mother, fetus, and newborn: influenza, mumps and measles. Clin Perinatol 15(2):259–272
LeBaron CW, Beeler J, Sullivan BJ, Forghani B, Bi D et al (2007) Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med 161(3):294–301
Manikkavasagan G, Ramsay M (2009) The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review. J Obstet Gynaecol 29(7):572–575
McLean H, Fiebelkorn AP, Temte JL, Wallace GS (2013) Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013. Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62(RR-04):1–34
Michel Y, Saloum K, Tournier C, Quinet B, Lassel L et al (2013) Rapid molecular diagnosis of measles virus infection in an epidemic setting. J Med Virol 85:723–730
Ohyama M, Fukui T, Tanaka Y, Kato K, Hoshino R et al (2001) Measles virus infection in the placenta of monozygotic twins. Mod Pathol 14(12):1300–1303
Ornoy A, Tenenbaum A (2006) Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol 21:446–457
Pardon F, Vilarino M, Barbero P, Garcia G, Outon E et al (2011) Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina. J Infect Dis 204 Suppl 2:S745–747
Poethko-Muller C, Mankertz A (2011) Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS). Vaccine 29:7949–7959
Poethko-Muller C, Mankertz A (2012) Seroprevalence of measles, mumps and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity. PloS one 7(8):e42867
Rabenau HF, Marianov B, Wicker S, Allwinn R (2007) Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations. Med Microbiol Immunol 196(3):151–155
Robert Koch-Institut (2013) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2013. Epidemiologisches Bulletin 34/2013
Robert Koch-Institut (2013) Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2011. Epidemiologisches Bulletin 16/2013
Robert Koch-Institut (2007) Liste der vom Robert Koch-Institut geprüften und anerkannten Desinfektionsmittel und -verfahren. Bundesgesundheitsblatt 50:1335–1356
Robert Koch-Institut (2010) Masern, RKI-Ratgeber für Ärzte
Sato HK, Sanajotta AT, Moraes JC, Andrade JQ, Duarte G et al (2011) Study Group for Effects of Rubella Vaccination During 2011. Rubella vaccination of unknowingly pregnant women: the Sao Paulo experience, 2001. J Infect Dis 204 Suppl 2:S737–744
Sheppeard V, Forssman B, Ferson MJ, Moreira C, Campbell-Lloyd S et al (2009) Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March – May 2006. Commun Dis Intell Q Rep. 33(1):21–26
Siegel M, Fuerst HT, Peress NS (1966) Comparative fetal mortality in maternal virus diseases. A prospective study on rubella, measles, mumps, chicken pox and hepatitis. N Engl J Med 274(14):768–771
Soares RC, Siqueira MM, Toscano CM, Maia Mde L, Flannery B et al (2011) Follow-up study of unknowingly pregnant women vaccinated against rubella in Brazil 2001–2002. J infect Dis 204 Suppl 2:S729–736
White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM (2012) Measles, mumps, and rubella. Clin Obstet Gynecol 55(2):550–559
WHO 2009 Immunological basis for immunization: Measles (Update 2009)
WHO 2010 Immunological basis for immunization: Mumps
WHO 2009 Measles vaccines: WHO position paper. Weekly epidemiological record No. 35:349–360
Yeung LF, Lurie P, Dayan G, Eduardo E, Britz PH et al (2005) A limited measles outbreak in a highly vaccinated US boarding school. Pediatr 116:1287–1291
Yoshida M, Matsuda H, Furuya K (2011) Two cases of measles in pregnant women immediately preceding delivery (case reports). Clin Exp Obstet Gynecol 38(2):177–179
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 DVV, GfV
About this chapter
Cite this chapter
Mankertz, A. (2014). Masern. In: S2k-Leitlinie - Labordiagnostik schwangerschaftsrelevanter Virusinfektionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43481-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-43481-9_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43480-2
Online ISBN: 978-3-662-43481-9
eBook Packages: Medicine (German Language)